Biomed has developed a family of patented drugs for the treatment of ALS, Alzheimer’s disease, major depressive disorder, diabetes obesity and rare diseases including Rett Syndrome and Fragile X.
NA-704: for the treatment and prevention Amyotrophic Lateral Sclerosis (ALS)
(Phase 2B)
NA-831: for the treatment and prevention of Mild and Moderate Alzheimer’s Disease (Phase 2B/3)
NA-901: for the treatment of Major Depressive Disorder (Phase 2B/3)
NA-911: for the treatment of Stroke (Phase 2A)
NA-921 (Bionetide): for the treatment of Rett Syndrome and Fragile X (Phase 2B/3)
NA-931: for the treatment of Diabetes Obesity (Phase 2B/3)
NA-941: for the treatment of Metabolic dysfunction-associated steatohepatitis (MASH) (Phase 2A)
MICROS: MICROS Infusion System (Approved by the FDA)
For further information about our products, please contact us by completing an Online Contact Form.
Thank you.
Learn more
